ResMed Inc. Financial Ratios — RME Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Return on Common Equity (%)	15.27	19.09	20.5	21.1	21.47	18.73	15.7	19.59	27.21	17.63	24.96	23.96	22.7	25.86	24.27
Return on Assets (%)	12.12	14.13	15.1	15.54	12.96	10.18	9.66	11.28	14.3	10.19	15.87	15.15	14.99	18.62	17.77
Return on Capital (%)	14.01	16.56	17.64	18.12	15.2	12.37	12.37	15.23	18.37	13.04	20.04	18.75	18.48	22.31	21.41
Return on Invested Capital (%)	12.13	14.74	16.13	16.63	14.28	11.63	11.76	15.26	18.87	12.38	19.54	18.25	18.32	21.96	20.67
Gross Margin (%)	59.97	62.11	63.65	60.24	58	56.72	57.04	57.32	58.09	57.53	56.57	55.78	56.67	59.36	61.06
EBITDA Margin (%)	27.79	28.6	30.77	28.73	28.05	26.03	28.28	28.01	33.51	34.26	33.37	31.48	32.79	37.33	37.69
Operating Margin (%)	21.51	23.43	26.46	24.38	23.7	22.1	23.94	24.4	27.36	28.54	28.01	27.28	29.54	32.75	33.76
Incremental Operating Margin (%)	21.92	41.4	139.67	- -	16.66	9.15	37.86	28.43	49.39	43.07	23.55	23.24	50.21	65.34	43.99
Pretax Margin (%)	24.26	25.43	27.72	25.96	23.91	20.26	22.28	19.91	24.79	27.64	26.84	26.09	27	32.6	33.95
Profit Margin (%)	18.62	20.28	22.2	21.02	19.17	16.56	13.49	15.52	21.02	14.84	21.78	21.25	21.79	27.22	26.94
Net Income to Common Margin (%)	18.62	20.28	22.2	21.02	19.17	16.56	13.49	15.52	21.02	14.84	21.78	21.25	21.79	27.22	26.94
Effective Tax Rate (%)	23.23	20.25	19.9	19.05	19.83	18.26	39.46	22.02	15.2	46.3	18.85	18.53	19.28	16.5	20.64
Dvd Payout Ratio (%)	- -	31.65	40.99	44.56	47.71	54.44	63.21	52.33	36.21	47.78	31.48	28.78	27.65	22.19	22.95
Sustainable Growth Rate (%)	15.27	13.05	12.1	11.69	11.23	8.53	5.78	9.34	17.36	9.21	17.1	17.07	16.43	20.12	18.7

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Total Debt	251	301	301	301	1,173	1,079	281	1,271	1,299	794	918	1,580	874	852	826
ST Debt	- -	300	- -	- -	299	- -	11	12	33	36	32	32	35	40	289
LT Debt	251	1	301	301	873	1,079	270	1,259	1,266	758	886	1,548	839	811	537
Total Debt/EBITDA	0.66	0.69	0.63	0.62	2.27	2.01	0.43	1.74	1.31	0.72	0.77	1.19	0.57	0.44	0.39
Net Debt/EBITDA	-1.47	-1.33	-1.26	-0.86	0.86	0.48	0.14	1.54	0.72	0.33	0.42	0.91	0.31	-0.28	-0.38
Total Debt/EBIT	0.85	0.85	0.74	0.73	2.73	2.53	0.52	2.19	1.6	0.88	0.92	1.4	0.66	0.51	0.44
Net Debt/EBIT	-1.9	-1.62	-1.49	-1.02	1.03	0.6	0.17	1.94	0.88	0.4	0.5	1.07	0.36	-0.32	-0.43
EBITDA to Interest Expense	79.45	67.81	78.08	83.47	46.03	19.05	23.34	20.19	24.54	45.65	53.52	28.06	33.61	- -	- -
EBITDA-CapEx/Interest Expense	66.69	56.57	64.84	71.02	39.98	16.52	20.82	18.05	21.92	40.78	46.53	25.23	31.09	- -	- -
EBIT to Interest Expense	61.51	55.55	67.13	70.83	38.9	16.18	19.76	17.59	20.04	38.03	44.92	24.31	30.28	- -	- -
Interest Expense	5	6	6	6	11	28	28	36	40	24	22	47	46	- -	- -
Common Equity/Total Assets	75.2	72.85	74.47	72.75	52.04	56.52	67.2	50.45	54.43	61.03	65.95	61.17	70.78	73.01	73.45
Long-Term Debt/Equity (%)	15.6	0.05	17.11	18.94	51.53	55.02	13.11	60.75	50.7	26.27	26.36	37.48	17.24	13.6	8.15
Long-Term Debt/Capital (%)	13.49	0.04	14.61	15.92	30.46	35.49	11.54	37.66	33.35	20.6	20.7	27.11	14.62	11.9	7.24
Long-Term Debt/Total Assets (%)	11.73	0.03	12.74	13.78	26.82	31.1	8.81	30.65	27.6	16.03	17.38	22.93	12.2	9.93	5.99
Total Debt/Equity (%)	15.6	18.68	17.11	18.94	69.2	55.02	13.67	61.33	52.03	27.51	27.3	38.26	17.97	14.27	12.54
Total Debt/Capital (%)	13.5	15.74	14.61	15.92	40.9	35.49	12.03	38.01	34.22	21.57	21.45	27.67	15.23	12.49	11.14
Total Debt/Total Assets (%)	11.73	13.61	12.74	13.78	36.01	31.1	9.19	30.94	28.32	16.79	18.01	23.4	12.72	10.42	9.21
Net Debt to Equity	-34.75	-35.72	-34.41	-26.25	26.04	13.09	4.5	54.23	28.55	12.48	14.92	29.38	9.64	-9.07	-12.3
Net Debt/Capital (%)	-53.26	-55.57	-52.45	-35.59	20.66	11.58	4.31	35.16	21.39	10.64	12.52	22.13	8.53	-9.65	-13.63
EBITDA	380	433	479	482	516	538	662	730	991	1,095	1,194	1,329	1,536	1,921	2,131
EBITDA-CapEx	319	361	397	410	448	466	590	653	885	978	1,038	1,195	1,421	1,821	1,954
Operating Income (Loss)	294	355	411	409	436	457	560	636	809	912	1,002	1,152	1,384	1,685	1,908

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Cash Ratio	3.2	1.53	3.36	2.69	1.15	2.28	0.37	0.26	0.77	0.32	0.4	0.3	0.26	1.19	1.05
Current Ratio	5.38	2.52	5.77	5.28	2.23	4.57	2.08	2.06	2.53	1.73	2.8	3.12	2.59	3.44	3.1
Quick Ratio	4.33	2.1	4.69	4.05	1.75	3.53	1.32	1.22	1.56	1	1.23	1.23	1.22	2.16	1.83
CFO/Avg Current Liab	1.66	0.97	0.93	1.43	1.21	0.83	1.16	0.86	1.38	0.97	0.44	0.96	1.68	1.82	1.5
Common Equity/Total Assets	75.2	72.85	74.47	72.75	52.04	56.52	67.2	50.45	54.43	61.03	65.95	61.17	70.78	73.01	73.45
Long-Term Debt/Equity (%)	15.6	0.05	17.11	18.94	51.53	55.02	13.11	60.75	50.7	26.27	26.36	37.48	17.24	13.6	8.15
Long-Term Debt/Capital (%)	13.49	0.04	14.61	15.92	30.46	35.49	11.54	37.66	33.35	20.6	20.7	27.11	14.62	11.9	7.24
Long-Term Debt/Total Assets (%)	11.73	0.03	12.74	13.78	26.82	31.1	8.81	30.65	27.6	16.03	17.38	22.93	12.2	9.93	5.99
Total Debt/Equity (%)	15.6	18.68	17.11	18.94	69.2	55.02	13.67	61.33	52.03	27.51	27.3	38.26	17.97	14.27	12.54
Total Debt/Capital (%)	13.5	15.74	14.61	15.92	40.9	35.49	12.03	38.01	34.22	21.57	21.45	27.67	15.23	12.49	11.14
Total Debt/Total Assets (%)	11.73	13.61	12.74	13.78	36.01	31.1	9.19	30.94	28.32	16.79	18.01	23.4	12.72	10.42	9.21
CFO/Total Liabilities	72.26	67.11	64.92	64.46	35.08	27.45	50.25	22.55	38.38	39.99	20.24	26.44	69.77	79.38	75.86
CFO/CapEx	6.27	5.61	4.82	5.33	8.08	5.79	7.07	5.94	7.57	6.31	2.25	5.17	12.2	17.4	10.19
Altman's Z-Score	7.94	9.8	10.48	11.72	7.12	8.29	13.61	10.21	12.65	16.28	15.57	11.89	13.45	15.03	11.84

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Accounts Receivable Turnover	4.91	5.04	4.59	4.65	4.94	4.96	5.01	5.15	5.9	5.87	6.01	6.59	6.08	5.79	5.72
Days Sales Outstanding	74.35	72.48	79.57	78.5	73.91	73.52	72.85	70.87	61.91	62.17	60.71	55.35	60.07	63.01	63.78
Inventory Turnover	2.92	3.58	3.63	3.24	3.28	3.63	3.74	3.6	3.23	3.11	2.59	2.14	2.23	2.39	2.35
Days Inventory Outstanding	124.98	101.84	100.51	112.72	111.39	100.54	97.49	101.44	112.89	117.47	141.05	170.24	163.64	152.71	155.3
Accounts Payable Turnover	9.46	9.43	8.01	9	8.63	10.13	10.84	11.45	10.39	10.21	12.38	13.69	9.55	8.52	7.56
Accounts Payable Turnover Days	38.58	38.72	45.59	40.58	42.27	36.05	33.66	31.88	35.13	35.75	29.47	26.67	38.24	42.86	48.27
Cash Conversion Cycle	160.75	135.61	134.48	150.64	143.02	138.02	136.68	140.43	139.67	143.89	172.29	198.93	185.48	172.86	170.81
Inventory to Cash Days	-50.63	-29.36	-20.94	-34.22	-37.48	-27.02	-24.64	-30.57	-50.98	-55.31	-80.35	-114.89	-103.57	-89.7	-91.52
Inventories	174	146	165	247	224	268	269	350	417	457	744	998	822	928	946
Raw Materials	66	47	54	74	67	76	75	81	128	155	355	459	356	367	396
Work In Process	2	2	3	3	4	4	2	2	3	5	3	4	3	3	3
Finished Goods	107	97	108	170	153	188	191	267	286	297	386	535	464	558	547
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Market Capitalization	4,318	6,652	7,085	7,815	8,595	11,035	15,017	17,343	27,506	35,561	31,228	31,675	28,055	37,748	28,846
- Cash & Cash Equivalents	810	876	906	717	731	822	189	147	463	295	274	228	238	1,209	1,469
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	251	301	301	301	1,173	1,079	281	1,271	1,299	794	918	1,580	874	852	826
Enterprise Value	3,759	6,077	6,480	7,399	9,037	11,291	15,110	18,467	28,342	36,060	31,872	33,027	28,690	37,390	28,203
Total Capital	1,858	1,911	2,059	1,888	2,868	3,039	2,340	3,343	3,796	3,679	4,278	5,710	5,738	6,820	7,411
Total Debt/Capital (%)	13.5	15.74	14.61	15.92	40.9	35.49	12.03	38.01	34.22	21.57	21.45	27.67	15.23	12.49	11.14
Total Debt / EV	0.07	0.05	0.05	0.04	0.13	0.1	0.02	0.07	0.05	0.02	0.03	0.05	0.03	0.02	0.03
EV/Sales	2.75	4.01	4.17	4.41	4.91	5.46	6.46	7.08	9.58	11.28	8.91	7.82	6.12	7.27	4.99
EV/EBITDA	9.89	14.03	13.54	15.34	17.52	20.99	22.83	25.3	28.6	32.93	26.69	24.84	18.68	19.46	13.24
EV/EBIT	12.77	17.13	16	18.08	21.07	26.52	27.89	31.88	35.01	39.9	31.86	29.18	21.74	22.19	14.95
EV/Cash Flow to Firm	9.72	14.9	16.36	19.08	16.23	25.83	28.94	37.9	33.88	48.11	86.31	45.13	19.95	21.35	15.62
EV/Free Cash Flow to Firm	11.54	18.08	20.57	23.42	18.48	30.88	33.52	45.05	38.8	56.99	149.48	55.24	21.68	22.65	17.32
Diluted Market Cap	4,540	6,858	7,290	7,938	8,657	11,056	15,154	17,443	27,651	35,757	31,363	31,760	28,179	37,994	29,209
Diluted Enterprise Value	3,981	6,283	6,685	7,522	9,098	11,313	15,247	18,567	28,487	36,255	32,007	33,112	28,814	37,636	28,566
EV per Share	26.47	42.79	46.19	52.67	64.24	79.42	105.9	128.55	195.62	247.58	217.69	224.58	195.3	255.42	195.53
TTM Sales	1,369	1,514	1,555	1,679	1,839	2,067	2,340	2,607	2,957	3,197	3,578	4,223	4,685	5,146	5,653
TTM EBITDA	380	433	479	482	516	538	662	730	991	1,095	1,194	1,329	1,536	1,921	2,131
TTM Operating Income	294	355	411	409	436	457	560	636	809	912	1,002	1,152	1,384	1,685	1,908
TTM Cash Flow to Firm	387	408	396	388	557	437	522	487	836	750	369	732	1,438	1,752	1,806
TTM Free Cash Flow to Firm	326	336	315	316	489	366	451	410	731	633	213	598	1,323	1,651	1,629

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023	06/30/2024	06/30/2025	06/30/2026

Price/Free Cash Flow	14.1	20.72	23.51	25.51	18.03	32.27	34.95	45.7	39.71	57.68	160.74	56.78	21.9	23.01	17.93
EV/EBIT	12.77	17.13	16	18.08	21.07	26.52	27.89	31.88	35.01	39.9	31.86	29.18	21.74	22.19	14.95
Enterprise Value	3,759	6,077	6,480	7,399	9,037	11,291	15,110	18,467	28,342	36,060	31,872	33,027	28,690	37,390	28,203
Low Price	23.06	30.63	41.92	46.52	49.24	55.29	72.57	93.43	113.72	168.72	190.14	205.65	136.28	188.14	183.24
EV/Sales	2.75	4.01	4.17	4.41	4.91	5.46	6.46	7.08	9.58	11.28	8.91	7.82	6.12	7.27	4.99
EV/EBITDA	9.89	14.03	13.54	15.34	17.52	20.99	22.83	25.3	28.6	32.93	26.69	24.84	18.68	19.46	13.24
Price/Earnings	17.41	21.8	20.69	22.15	24.32	32.05	47.61	42.7	44.08	74.77	39.97	35.22	27.5	27.01	19.11
Price/Earnings Average	16.74	19.37	19.75	22.84	22.3	27.5	40.05	38.04	34.65	60.78	46.37	36.26	25.97	24.51	23.6
Price/Earnings High	20	23.7	23.38	29.7	24.73	32.55	48.8	43.71	44.08	75.78	56.65	39.62	32.58	27.11	27.75
Price/Earnings Low	13.2	14.26	17.18	18.52	19.6	22.83	32.83	33.05	26.4	51.67	35.63	33.63	19.63	19.71	17.5
Price/Book Value	2.69	4.13	4.03	4.92	5.07	5.63	7.29	8.37	11.02	12.32	9.29	7.67	5.77	6.33	4.38
Price/Book Value Average	2.58	3.67	3.85	5.08	4.65	4.83	6.13	7.46	8.66	10.02	10.78	7.9	5.45	5.74	5.41
Price/Book Value High	3.09	4.49	4.55	6.6	5.16	5.72	7.47	8.57	11.02	12.49	13.17	8.63	6.83	6.35	6.36
Price/Book Value Low	2.04	2.7	3.35	4.12	4.09	4.01	5.03	6.48	6.6	8.52	8.28	7.32	4.12	4.61	4.01
Price/Tangible Book Value	3.33	5.17	4.98	6.13	25.6	17.42	19.38	-56.64	173.5	62.92	28.96	39.24	18.26	15.37	8.95
Price/Tangible Book Value Average	3.2	4.6	4.75	6.32	23.47	14.94	16.3	-50.45	136.38	51.14	33.59	40.4	17.25	13.94	11.06
Price/Tangible Book Value High	3.83	5.62	5.62	8.21	26.03	17.69	19.86	-57.97	173.5	63.77	41.04	44.14	21.64	15.43	13
Price/Tangible Book Value Low	2.53	3.38	4.13	5.12	20.63	12.41	13.36	-43.83	103.93	43.48	25.82	37.46	13.03	11.21	8.2
Price/Sales	3.24	4.42	4.59	4.65	4.66	5.31	6.42	6.63	9.27	11.1	8.71	7.49	5.99	7.35	5.15
Price/Sales Average	3.12	3.93	4.39	4.8	4.27	4.55	5.4	5.9	7.28	9.02	10.1	7.71	5.66	6.67	6.36
Price/Sales High	3.72	4.81	5.19	6.24	4.74	5.39	6.58	6.78	9.27	11.25	12.34	8.42	7.1	7.38	7.48
Price/Sales Low	2.46	2.89	3.81	3.89	3.76	3.78	4.43	5.13	5.55	7.67	7.76	7.15	4.28	5.36	4.72
Price/Cash Flow	11.58	16.62	18.26	20.39	15.64	26.5	29.75	37.64	34.16	48.16	88.72	45.59	20.04	21.6	16.12
Price/Cash Flow Average	11.14	14.77	17.43	21.03	14.34	22.73	25.03	33.53	26.85	39.15	102.92	46.95	18.92	19.6	19.91
Price/Cash Flow High	13.3	18.07	20.64	27.35	15.9	26.91	30.49	38.52	34.16	48.81	125.75	51.29	23.74	21.68	23.41
Price/Cash Flow Low	8.78	10.87	15.16	17.05	12.6	18.88	20.51	29.13	20.46	33.28	79.09	43.53	14.3	15.76	14.77
Price/Free Cash Flow Average	13.56	18.4	22.44	26.3	16.53	27.69	29.4	40.71	31.21	46.89	186.47	58.47	20.69	20.88	22.16
Price/Free Cash Flow High	16.19	22.52	26.57	34.2	18.34	32.77	35.82	46.77	39.71	58.46	227.83	63.88	25.95	23.1	26.05
Price/Free Cash Flow Low	10.69	13.55	19.51	21.33	14.53	22.99	24.1	35.36	23.79	39.86	143.29	54.22	15.63	16.79	16.43
EV/Sales Average	2.63	3.52	3.96	4.55	4.53	4.7	5.44	6.36	7.59	9.2	10.3	8.04	5.79	6.59	6.19
EV/Sales High	3.22	4.39	4.76	5.99	4.99	5.55	6.62	7.24	9.58	11.43	12.55	8.76	7.23	7.29	7.3
EV/Sales Low	1.98	2.49	3.39	3.64	4.01	3.93	4.46	5.58	5.85	7.84	7.96	7.48	4.41	5.28	4.56
EV/EBITDA Average	9.45	12.32	12.87	15.85	16.14	18.07	19.23	22.7	22.66	26.85	30.88	25.55	17.66	17.64	16.42
EV/EBITDA High	11.58	15.37	15.47	20.87	17.8	21.31	23.4	25.85	28.6	33.36	37.6	27.82	22.05	19.54	19.36
EV/EBITDA Low	7.14	8.72	11.03	12.68	14.28	15.09	15.79	19.92	17.47	22.89	23.85	23.77	13.45	14.15	12.1
EV/EBIT Average	12.21	15.03	15.2	18.67	19.4	22.83	23.48	28.61	27.74	32.54	36.86	30.01	20.55	20.11	18.55
EV/EBIT High	14.95	18.76	18.27	24.59	21.41	26.92	28.58	32.58	35.01	40.44	44.89	32.67	25.66	22.27	21.86
EV/EBIT Low	9.22	10.64	13.03	14.95	17.18	19.06	19.28	25.11	21.38	27.75	28.47	27.91	15.65	16.13	13.67
Last Price	30.4	46.84	50.5	55.63	61.11	77.61	105.25	120.73	189.84	244.16	213.29	215.38	190.98	257.87	199.99
High Price	34.93	50.91	57.07	74.61	62.14	78.82	107.87	123.56	189.84	247.46	302.3	242.28	226.25	258.84	290.45
Enterprise Value Average	3,595	5,334	6,159	7,642	8,323	9,723	12,724	16,572	22,457	29,405	36,870	33,966	27,129	33,891	34,994
Enterprise Value High	4,402	6,655	7,402	10,064	9,182	11,463	15,483	18,874	28,342	36,541	44,904	36,983	33,872	37,533	41,251
Enterprise Value Low	2,716	3,775	5,277	6,118	7,368	8,117	10,447	14,545	17,313	25,073	28,482	31,596	20,655	27,184	25,787

Shares Outstanding	142	142	140	140	141	142	143	144	145	146	146	147	147	146	144
Diluted Weighted Avg Shares	149	146	144	143	142	142	144	144	146	146	147	147	148	147	146
Basic Weighted Avg Shares	146	143	141	140	140	141	143	143	144	145	146	147	147	147	146
Revenue per Share	9.38	10.59	10.99	11.95	13.11	14.62	16.39	18.21	20.49	22	24.5	28.77	31.87	35.08	38.85
EBITDA per Share	2.61	3.03	3.38	3.43	3.68	3.81	4.64	5.1	6.87	7.54	8.18	9.06	10.45	13.09	14.64
Operating Income per Share	2.02	2.48	2.91	2.91	3.11	3.23	3.92	4.44	5.61	6.28	6.86	7.85	9.41	11.49	13.11
Basic EPS, GAAP	1.75	2.15	2.44	2.51	2.51	2.42	2.21	2.83	4.31	3.27	5.34	6.12	6.94	9.55	10.47
Basic EPS from Cont Ops	1.75	2.15	2.44	2.51	2.51	2.42	2.21	2.83	4.31	3.27	5.34	6.12	6.94	9.55	10.47
Diluted EPS, GAAP	1.71	2.1	2.39	2.47	2.49	2.4	2.19	2.8	4.27	3.24	5.3	6.09	6.92	9.51	10.43
Diluted EPS from Cont Ops	1.71	2.1	2.39	2.47	2.49	2.4	2.19	2.8	4.27	3.24	5.3	6.09	6.92	9.51	10.43
Dividend per Share	- -	0.68	1	1.12	1.2	1.32	1.4	1.48	1.56	1.56	1.68	1.76	1.92	2.12	2.4
Cash Flow per Share	2.63	2.82	2.77	2.73	3.91	2.93	3.54	3.21	5.56	5.07	2.4	4.72	9.53	11.94	12.41
Free Cash Flow per Basic Share	2.21	2.32	2.19	2.22	3.42	2.42	3.04	2.67	4.82	4.27	1.34	3.81	8.75	11.25	11.19
Cash & Equivalents per Share	5.7	6.17	6.46	5.11	5.2	5.78	1.32	1.02	3.2	2.03	1.87	1.55	1.62	8.26	10.19
Book Value per Share	11.32	11.34	12.53	11.3	12.05	13.79	14.43	14.42	17.23	19.81	22.95	28.08	33.11	40.77	45.66
Tangible Book Value per Share	9.13	9.06	10.15	9.08	2.39	4.46	5.43	-2.13	1.09	3.88	7.37	5.49	10.46	16.78	22.35

ResMed Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)